Research And Development
Europe
Health
AstraZeneca
$42.599876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$42.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.36 (-0.84%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell AstraZeneca and other stocks, options, ETFs, and crypto commission-free!
About
AstraZeneca PLC, also called AstraZeneca, is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Read More Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Employees
64,400
Headquarters
Cambridge, Cambridgeshire
Founded
1992
Market Cap
107.93B
Price-Earnings Ratio
50.22
Dividend Yield
3.61
Average Volume
4.36M
High Today
$42.86
Low Today
$42.42
Open Price
$42.45
Volume
1.31M
52 Week High
$43.30
52 Week Low
$34.29
Collections
Research And Development
Europe
Health
Manufacturing
Cancer Prevention
Biotechnology
Medical
Biopharmaceutical
News
ReutersMar 22
FTSE 100 sinks as sterling gains on Brexit relief
(Reuters) - London’s FTSE 100 retreated from multi-month highs as the pound gained, weakening exporter stocks, and poor euro zone economic data pulled the index deeper into the red.
Markets InsiderMar 21
North America Glucagon like Peptide - 1 Agonists Market 2019-2024 by Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide) & Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
DUBLIN, March 21, 2019 /PRNewswire/ -- The "North America Glucagon like Peptide - 1 (GLP - 1) Agonists Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.
Yahoo FinanceMar 21
If you like AstraZeneca, you could love this health-focused small-cap
Pharmaceutical giant AstraZeneca is forecast to post some impressive advances in earnings. But I think there’s also great potential for investors in healthcare-focused advisory company Cello Health (LSE: CLL). The firm describes itself as a “global healthcare-focused advisory group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities.” There’s an office network in the UK, USA, and Asia and the company reckons it deals with “24 of the top 25 pharmaceutical clients gl...
Price Paid on Robinhood
21% Higher
Right Now
52 Week Low
$34.29
Average Price Paid
$35.22
52 Week High
$43.30
Earnings
$0.29
$0.72
$1.15
$1.58
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Available Apr 26, Pre-Market